Title |
Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy
|
---|---|
Published in |
Frontiers in Neuroanatomy, February 2016
|
DOI | 10.3389/fnana.2016.00006 |
Pubmed ID | |
Authors |
Marina Boido, Alessandro Vercelli |
Abstract |
Spinal muscular atrophy (SMA) is a recessive autosomal neuromuscular disease, representing the most common fatal pediatric pathology. Even though, classically and in a simplistic way, it is categorized as a motor neuron (MN) disease, there is an increasing general consensus that its pathogenesis is more complex than expected. In particular, neuromuscular junctions (NMJs) are affected by dramatic alterations, including immaturity, denervation and neurofilament accumulation, associated to impaired synaptic functions: these abnormalities may in turn have a detrimental effect on MN survival. Here, we provide a description of NMJ development/maintenance/maturation in physiological conditions and in SMA, focusing on pivotal molecules and on the time-course of pathological events. Moreover, since NMJs could represent an important target to be exploited for counteracting the pathology progression, we also describe several therapeutic strategies that, directly or indirectly, aim at NMJs. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Korea, Republic of | 1 | <1% |
Italy | 1 | <1% |
Unknown | 130 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 31 | 23% |
Student > Master | 17 | 13% |
Student > Bachelor | 15 | 11% |
Other | 10 | 8% |
Researcher | 7 | 5% |
Other | 16 | 12% |
Unknown | 36 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 25 | 19% |
Neuroscience | 23 | 17% |
Agricultural and Biological Sciences | 18 | 14% |
Medicine and Dentistry | 14 | 11% |
Engineering | 3 | 2% |
Other | 8 | 6% |
Unknown | 41 | 31% |